These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22171588)

  • 61. [The use of recombinant activated factor VIIa for major bleedings in open heart surgery].
    Ingimarsson JP; Onundarson PT; Valsson F; Vidarsson B; Gudbjartsson T
    Laeknabladid; 2008 Sep; 94(9):607-12. PubMed ID: 18784387
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled study.
    Zhang XH; Zhu XL; Niu T; Sun J; Liu H; Feng R; Yang LH; Wei Q; Ma QH; Wang QM; Feng FE; Fu HX; Mo XD; Lv M; Huang XJ
    Thromb Res; 2015 May; 135(5):835-40. PubMed ID: 25747536
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intracerebral hemorrhage in patients receiving oral anticoagulation therapy.
    da Silva IR; Provencio JJ
    J Intensive Care Med; 2015 Feb; 30(2):63-78. PubMed ID: 23753250
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Management of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentrates.
    Baumann Kreuziger LM; Keenan JC; Morton CT; Dries DJ
    Biomed Res Int; 2014; 2014():583794. PubMed ID: 25136597
    [TBL] [Abstract][Full Text] [Related]  

  • 65. When Will Fondaparinux Induce Thrombocytopenia?
    Chen LY; Khan N; Lindenbauer A; Nguyen TH
    Bioconjug Chem; 2022 Aug; 33(8):1574-1583. PubMed ID: 35878320
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Position paper of the Italian Society of Internal Medicine (SIMI) on prophylaxis and treatment of venous thromboembolism in patients with cancer.
    Prisco D; Tufano A; Cenci C; Pignatelli P; Santilli F; Di Minno G; Perticone F
    Intern Emerg Med; 2019 Jan; 14(1):21-38. PubMed ID: 30276659
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.
    Smythe MA; Priziola J; Dobesh PP; Wirth D; Cuker A; Wittkowsky AK
    J Thromb Thrombolysis; 2016 Jan; 41(1):165-86. PubMed ID: 26780745
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.
    Frontera JA; Lewin JJ; Rabinstein AA; Aisiku IP; Alexandrov AW; Cook AM; del Zoppo GJ; Kumar MA; Peerschke EI; Stiefel MF; Teitelbaum JS; Wartenberg KE; Zerfoss CL
    Neurocrit Care; 2016 Feb; 24(1):6-46. PubMed ID: 26714677
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of acute subdural hematoma.
    Gerard C; Busl KM
    Curr Treat Options Neurol; 2014 Jan; 16(1):275. PubMed ID: 24363148
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach.
    Donadini MP; Ageno W; Douketis JD
    Drugs; 2012 Oct; 72(15):1965-75. PubMed ID: 23039318
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recombinant factor VIIa to manage major bleeding from newer parenteral anticoagulants.
    Vavra KA; Lutz MF; Smythe MA
    Ann Pharmacother; 2010 Apr; 44(4):718-26. PubMed ID: 20233918
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates.
    Perzborn E; Gruber A; Tinel H; Marzec UM; Buetehorn U; Buchmueller A; Heitmeier S; Laux V
    Thromb Haemost; 2013 Jul; 110(1):162-72. PubMed ID: 23636219
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Emergency reversal of pentasaccharide anticoagulants: a systematic review of the literature.
    Elmer J; Wittels KA
    Transfus Med; 2012 Apr; 22(2):108-15. PubMed ID: 22171588
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.
    Perzborn E; Heitmeier S; Laux V; Buchmüller A
    Thromb Res; 2014 Apr; 133(4):671-81. PubMed ID: 24529498
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reversal of new, factor-specific oral anticoagulants by rFVIIa, prothrombin complex concentrate and activated prothrombin complex concentrate: a review of animal and human studies.
    Lee FM; Chan AK; Lau KK; Chan HH
    Thromb Res; 2014 May; 133(5):705-13. PubMed ID: 24666649
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.